DD129783A5 - Verfahren zur herstellung eines enons - Google Patents

Verfahren zur herstellung eines enons

Info

Publication number: DD129783A5
Authority: DD; German Democratic Republic
Prior art keywords: enon; preparing
Prior art date: 1974-12-11

Application number

DD7500197925A

Other languages

English (en)

Inventor

Michael R Johnson

Jasjit S Bindra

Hans-Juergen E Hess

Thomas K Schaaf

James F Eggler

Original Assignee

Pfizer

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1974-12-11

Filing date

1975-12-11

Publication date

1978-02-08

1975-12-11 Application filed by Pfizer filed Critical Pfizer

1978-02-08 Publication of DD129783A5 publication Critical patent/DD129783A5/de

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
- C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C61/00—Compounds having carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings
- C07C61/06—Saturated compounds having a carboxyl group bound to a five-membered ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/74—Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/10—Oxygen atoms
- C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1896—Compounds having one or more Si-O-acyl linkages
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4006—Esters of acyclic acids which can have further substituents on alkyl
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4056—Esters of arylalkanephosphonic acids
- C07F9/4059—Compounds containing the structure (RY)2P(=X)-(CH2)n-C(=O)-(CH2)m-Ar, (X, Y = O, S, Se; n>=1, m>=0)

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Crystallography & Structural Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Emergency Medicine (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Furan Compounds (AREA)
Pyrane Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

DD7500197925A 1974-12-11 1975-12-11 Verfahren zur herstellung eines enons DD129783A5 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US53167674A	1974-12-11	1974-12-11

Publications (1)

Publication Number	Publication Date
DD129783A5 true DD129783A5 (de)	1978-02-08

Family

ID=24118594

Family Applications (3)

Application Number	Title	Priority Date	Filing Date
DD7500197925A DD129783A5 (de)	1974-12-11	1975-12-11	Verfahren zur herstellung eines enons
DD7500197926A DD129649A5 (de)	1974-12-11	1975-12-11	Verfahren zur herstellung von zwischenprodukten fuer die herstellung von analogen von natuerlich vorkommenden prostaglandinen
DD190054A DD125828A5 (de)	1974-12-11	1975-12-11

Family Applications After (2)

Application Number	Title	Priority Date	Filing Date
DD7500197926A DD129649A5 (de)	1974-12-11	1975-12-11	Verfahren zur herstellung von zwischenprodukten fuer die herstellung von analogen von natuerlich vorkommenden prostaglandinen
DD190054A DD125828A5 (de)	1974-12-11	1975-12-11

Country Status (22)

Country	Link
JP (3)	JPS51125257A (de)
AT (1)	AT351185B (de)
BE (1)	BE836564A (de)
BG (1)	BG27227A3 (de)
CH (1)	CH610302A5 (de)
CS (3)	CS194746B2 (de)
DD (3)	DD129783A5 (de)
DE (1)	DE2555210A1 (de)
DK (1)	DK559975A (de)
ES (1)	ES443421A1 (de)
FI (1)	FI753475A (de)
FR (1)	FR2293923A1 (de)
GB (3)	GB1508168A (de)
GR (1)	GR60310B (de)
IE (1)	IE43815B1 (de)
IL (2)	IL48617A0 (de)
LU (1)	LU73997A1 (de)
NL (1)	NL166015C (de)
NO (1)	NO754195L (de)
NZ (1)	NZ179502A (de)
SE (1)	SE7513602L (de)
ZA (1)	ZA747723B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5486540A (en) *	1993-10-28	1996-01-23	Allergan, Inc.	Cyclopentane heptanoic or heptenoic acid, 2-arylalkyl or arylalkenyl and derivatives as therapeutic agents
WO2000015608A1 (en) *	1998-09-14	2000-03-23	Ono Pharmaceutical Co., Ltd.	φ-SUBSTITUTED PHENYL-PROSTAGLANDIN E DERIVATIVES AND DRUGS CONTAINING THE SAME AS THE ACTIVE INGREDIENT
US9284274B2 (en)	2005-12-07	2016-03-15	Ramot At Tel-Aviv University Ltd.	Chemical derivatives of jasmonate, pharmaceutical compositions and methods of use thereof
DK2617714T3 (da) *	2005-12-07	2016-06-27	Univ Ramot	Kemiske derivater af jasmonat, farmaceutiske præparater og fremgangsmåder til anvendelse deraf
US9284252B2 (en)	2009-06-09	2016-03-15	Sepal Pharma Ltd.	Use of jasmonate ester derivatives for treating benign hyperproliferative skin disorders
AU2013292357C1 (en)	2012-07-19	2017-05-25	Cayman Chemical Company, Inc.	Difluorolactam compounds as EP4 receptor-selective agonists for use in the treatment of EP4-mediated disease and conditions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NO143741C (no) *	1972-07-13	1981-04-08	Pfizer	Analogifremgangsmaate for fremstilling av fysiologisk aktive prostaglandinforbindelser av e- og f-serien

1974
- 1974-12-04 ZA ZA747723A patent/ZA747723B/xx unknown
1975
- 1975-11-11 GR GR49337A patent/GR60310B/el unknown
- 1975-12-02 SE SE7513602A patent/SE7513602L/xx unknown
- 1975-12-03 IE IE2635/75A patent/IE43815B1/en unknown
- 1975-12-08 IL IL48617A patent/IL48617A0/xx unknown
- 1975-12-09 DE DE19752555210 patent/DE2555210A1/de active Pending
- 1975-12-10 FI FI753475A patent/FI753475A/fi not_active Application Discontinuation
- 1975-12-10 GB GB50700/75A patent/GB1508168A/en not_active Expired
- 1975-12-10 NZ NZ179502A patent/NZ179502A/xx unknown
- 1975-12-10 GB GB29060/77A patent/GB1508169A/en not_active Expired
- 1975-12-10 DK DK559975A patent/DK559975A/da not_active Application Discontinuation
- 1975-12-10 NO NO754195A patent/NO754195L/no unknown
- 1975-12-10 GB GB29061/77A patent/GB1508170A/en not_active Expired
- 1975-12-11 FR FR7537944A patent/FR2293923A1/fr active Granted
- 1975-12-11 BE BE1007076A patent/BE836564A/xx not_active IP Right Cessation
- 1975-12-11 LU LU73997A patent/LU73997A1/xx unknown
- 1975-12-11 NL NL7514446.A patent/NL166015C/xx not_active IP Right Cessation
- 1975-12-11 ES ES443421A patent/ES443421A1/es not_active Expired
- 1975-12-11 DD DD7500197925A patent/DD129783A5/de unknown
- 1975-12-11 AT AT941675A patent/AT351185B/de not_active IP Right Cessation
- 1975-12-11 CH CH1610875A patent/CH610302A5/xx not_active IP Right Cessation
- 1975-12-11 JP JP50148319A patent/JPS51125257A/ja active Pending
- 1975-12-11 CS CS771242A patent/CS194746B2/cs unknown
- 1975-12-11 DD DD7500197926A patent/DD129649A5/de unknown
- 1975-12-11 BG BG031757A patent/BG27227A3/bg unknown
- 1975-12-11 CS CS771241A patent/CS194745B2/cs unknown
- 1975-12-11 DD DD190054A patent/DD125828A5/xx unknown
- 1975-12-11 CS CS758428A patent/CS194733B2/cs unknown
1977
- 1977-03-11 JP JP2687477A patent/JPS52102270A/ja active Pending
- 1977-03-11 JP JP2687577A patent/JPS52102258A/ja active Pending
1979
- 1979-03-13 IL IL56863A patent/IL56863A0/xx unknown

Also Published As

Publication number	Publication date
NL7514446A (nl)	1976-06-15
NL166015C (nl)	1981-06-15
SE7513602L (sv)	1976-06-14
JPS52102270A (en)	1977-08-27
NZ179502A (en)	1979-01-11
FI753475A (de)	1976-06-12
IE43815L (en)	1976-06-11
GB1508169A (en)	1978-04-19
ZA747723B (en)	1976-11-24
JPS51125257A (en)	1976-11-01
FR2293923B1 (de)	1979-02-23
GB1508170A (en)	1978-04-19
FR2293923A1 (fr)	1976-07-09
CS194745B2 (en)	1979-12-31
CH610302A5 (en)	1979-04-12
DD125828A5 (de)	1977-05-18
NO754195L (de)	1976-06-14
NL166015B (nl)	1981-01-15
IL48617A0 (en)	1976-02-29
IE43815B1 (en)	1981-06-03
CS194733B2 (en)	1979-12-31
JPS52102258A (en)	1977-08-27
ES443421A1 (es)	1977-04-16
DD129649A5 (de)	1978-02-01
AU8736275A (en)	1977-10-13
LU73997A1 (de)	1976-11-11
GR60310B (en)	1978-05-08
DE2555210A1 (de)	1976-06-16
ATA941675A (de)	1978-12-15
AT351185B (de)	1979-07-10
BG27227A3 (bg)	1979-09-14
DK559975A (da)	1976-06-12
IL56863A0 (en)	1979-05-31
CS194746B2 (en)	1979-12-31
GB1508168A (en)	1978-04-19
BE836564A (fr)	1976-06-11

Publication	Publication Date	Title
AT340134B (de)	1977-11-25	Verfahren zur herstellung verzweigter polymerisate
DD129644A5 (de)	1978-02-01	Verfahren zur herstellung neuer prostaglandinvorprodukte
AT339051B (de)	1977-09-26	Verfahren zur herstellung eines anorganisch-organischen kunststoffes
DE2551961A1 (de)	1976-05-26	Verfahren zur herstellung eines halbleiterbauelementes
AT342789B (de)	1978-04-25	Verfahren zur herstellung eines injizierbaren komplexes
AT344865B (de)	1978-08-10	Verfahren zur herstellung eines effektgarns
AT341668B (de)	1978-02-27	Verfahren zur herstellung von 7-aminocephemverbindungen
ATA845575A (de)	1977-05-15	Verfahren zur herstellung neuer substituierter benzophenone
AT343109B (de)	1978-05-10	Verfahren zur herstellung von indoleninderivaten
AT342015B (de)	1978-03-10	Verfahren zur herstellung von acetoacetamid-n-sulfofluorid
ATA308376A (de)	1978-02-15	Verfahren zur herstellung eines reaktionsmittels zur entfernung von phosphationen
DD129783A5 (de)	1978-02-08	Verfahren zur herstellung eines enons
ATA986075A (de)	1979-10-15	Verfahren zur herstellung neuer indolderivate
AT351768B (de)	1979-08-10	Verfahren zur herstellung eines antistruktur- mittelgemisches
AT335485B (de)	1977-03-10	Verfahren zur herstellung eines harnstoff-formaldehyd-dungers
DD130935A5 (de)	1978-05-17	Verfahren zur herstellung von propionsaeureestern
ATA924875A (de)	1979-12-15	Verfahren zur herstellung neuer 5-nitroimida- zolderivate
DD122964A5 (de)	1976-11-12	Verfahren zur herstellung von prostensaeurederivaten
DD130933A5 (de)	1978-05-17	Verfahren zur herstellung von sulfinylazetidinonen
AT346366B (de)	1978-11-10	Verfahren zur gewinnung eines n-acylierten orgoteins
AT351523B (de)	1979-07-25	Verfahren zur herstellung von 2-alkyl-5- nitroimidazolderivaten
AT338974B (de)	1977-09-26	Verfahren zur herstellung von 7-amino-delta3-cephem-derivaten
AT340885B (de)	1978-01-10	Verfahren zur herstellung von acetoacetamid-n-sulfofluorid
ATA625774A (de)	1975-09-15	Verfahren zur herstellung von phenylpyridazonen
AT341898B (de)	1978-03-10	Verfahren zur herstellung eines oxydischen schleifmittels